raloxifene hydrochloride has been researched along with Aging in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 18 (66.67) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, RP; Chaves-Neto, AH; Dornelles, RCM; Ervolino, E; Fernandes, F; Louzada, MJQ; Morais, SRL; Perez-Ueno, MJ; Stringhetta-Garcia, CT | 1 |
| Chaves-Neto, AH; Dornelles, RC; Ervolino, E; Louzada, MJ; Nakamune, AC; Rossi, AC; Santos, LF; Singulani, MP; Stringhetta-Garcia, CT | 1 |
| Lovre, D; Mauvais-Jarvis, F; Xu, B | 1 |
| Ohta, H | 1 |
| Verhaar, HJ | 1 |
| Sharpe, DT; Stevenson, S; Thornton, MJ | 1 |
| Azcoitia, I; Barreto, G; Carrero, P; Diz-Chaves, Y; Garcia-Segura, LM; Pernía, O; Santos-Galindo, M | 1 |
| Ichikawa, S; Sumino, H | 1 |
| Miyakoshi, N | 1 |
| Chen, LF; Du, XL; Ma, HS; Ma, YX; Shi, JD; Yang, R; Yang, ZP; Zhang, J; Zhou, Y; Zhu, Y | 1 |
| Dantas, AP; Heras, M; Hermenegildo, C; Novella, S | 1 |
| Trivedi, MA; Zec, RF | 1 |
| Hengemihle, J; Ingram, DK; Lei, DL; Long, JM; Manaye, KF; Mouton, PR; O'Neill, J | 1 |
| Brinton, RD; Chen, S; O'Neill, K | 1 |
| Barkhof, F; Duschek, EJ; Goekoop, R; Knol, DL; Netelenbos, C; Rombouts, SA; Scheltens, P | 1 |
| Mijatovic, V; van der Mooren, MJ; Vogelvang, TE | 1 |
| Duschek, EJ; Gooren, LJ; Netelenbos, C | 1 |
| Bleiberg, I; Kaye, AM; Ofer, M; Somjen, D | 1 |
| Au, CL; Fung, KP; Huang, Y; Laher, I; Tsang, SY; Vanhoutte, PM; Wong, CM; Yao, X | 1 |
| Mashiba, T | 1 |
| Bryant, HU; Kim, J; Sato, M; Short, LL; Slemenda, CW | 1 |
| Bryant, HU; Evans, G; Magee, D; Sato, M; Turner, RT | 1 |
| Black, D; Cox, D; Cummings, S; Duong, T; Lips, P; Nickelsen, T; Oleksik, A | 1 |
| Aguilar, E; Gaytán, F; González, LC; Pinilla, L; Tena-Sempere, M | 1 |
| Butterworth, M; Greaves, P; Green, A; Parrott, E; White, IN | 1 |
| Ammann, P; Bonjour, JP; Bourrin, S; Rizzoli, R | 1 |
| Clarkson, TB; Mikkola, TS | 1 |
8 review(s) available for raloxifene hydrochloride and Aging
| Article | Year |
|---|---|
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2017 |
[Role of estrogen and selective estrogen receptor modulators in anti-aging].
Topics: Aging; Animals; Bone and Bones; Bone Density; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Fractures, Bone; Humans; Osteoporosis; Perimenopause; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators | 2008 |
[Effects of SERMs on bone health. SERM actions other than on the bones. With special reference to the actions of SERM on the skin and vascular elasticity].
Topics: Aging; Arteries; Bone Density Conservation Agents; Elasticity; Estrogens; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Skin; Skin Physiological Phenomena | 2010 |
[Musculoskeletal rehabilitation and bone. Influence of medicines and hormones on musculoskeletal rehabilitation].
Topics: Accidental Falls; Aging; Bone Density Conservation Agents; Diphosphonates; Estrogen Replacement Therapy; Exercise; Female; Gonadal Steroid Hormones; Humans; Musculoskeletal Diseases; Musculoskeletal System; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Sarcopenia; Vitamin D | 2010 |
The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.
Topics: Aging; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Cognition; Dementia; Estrogen Replacement Therapy; Female; Humans; Memory; Neuropsychological Tests; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators | 2002 |
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2004 |
[Assessment of bone quality. Bone quality and osteoporosis treatment].
Topics: Aging; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Calcification, Physiologic; Diphosphonates; Female; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2008 |
Estrogen replacement therapy, atherosclerosis, and vascular function.
Topics: Aged; Aging; Animals; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Inflammation; Isoflavones; Lipids; Macaca; Male; Middle Aged; Models, Animal; Phytoestrogens; Plant Preparations; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
3 trial(s) available for raloxifene hydrochloride and Aging
| Article | Year |
|---|---|
Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior.
Topics: Aged; Aging; Arousal; Attention; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Double-Blind Method; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Mental Recall; Middle Aged; Pattern Recognition, Visual; Problem Solving; Raloxifene Hydrochloride; Reference Values; Retention, Psychology; Selective Estrogen Receptor Modulators; Statistics as Topic | 2005 |
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aging; Double-Blind Method; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Multivariate Analysis; Raloxifene Hydrochloride; Testosterone; Transsexualism | 2005 |
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Aging; Alkaline Phosphatase; Bone Density; Calcifediol; Calcium; Cholecalciferol; Female; Humans; Immunoradiometric Assay; Middle Aged; Nutritional Status; Osteoporosis, Postmenopausal; Parathyroid Hormone; Postmenopause; Radioimmunoassay; Raloxifene Hydrochloride; Seasons | 2001 |
16 other study(ies) available for raloxifene hydrochloride and Aging
| Article | Year |
|---|---|
Effects of strength training and raloxifene on femoral neck metabolism and microarchitecture of aging female Wistar rats.
Topics: Aging; Animals; Bone Density; Bone Density Conservation Agents; Combined Modality Therapy; Female; Femur Neck; Osteoblasts; Osteoclasts; Osteoporosis; Phosphates; Raloxifene Hydrochloride; Random Allocation; Rats, Wistar; Resistance Training; Tartrate-Resistant Acid Phosphatase | 2017 |
The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
Topics: Aging; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Femur; Imaging, Three-Dimensional; Organ Size; Ovariectomy; Raloxifene Hydrochloride; Rats, Wistar; Resistance Training; Uterus | 2016 |
[Treatment of osteoporosis in the elderly: what is the evidence?].
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alendronate; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Evidence-Based Medicine; Female; Fractures, Bone; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risedronic Acid; Teriparatide; Treatment Outcome | 2008 |
Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay.
Topics: Aging; Cell Movement; DNA; Estrogen Receptor alpha; Estrogens; Female; Fibroblasts; Humans; In Vitro Techniques; Middle Aged; Models, Biological; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Skin; Tamoxifen; Wound Healing | 2009 |
Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones.
Topics: Aging; Animals; Astrocytes; Brain; Brain Injuries; Estradiol; Estrogens; Female; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen; Vimentin | 2009 |
Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aging; Animals; Cell Line; Cell Proliferation; Estrogen Antagonists; Finasteride; Humans; Male; Models, Animal; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |
Effects of estrogen on vascular inflammation: a matter of timing.
Topics: Adult; Aged; Aging; Biomarkers; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Interleukin-6; Menopause; Middle Aged; Raloxifene Hydrochloride; Time Factors; Vasculitis | 2012 |
Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice.
Topics: Aging; Animals; Cell Count; Estrogen Antagonists; Estrogens; Female; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; Macrophage-1 Antigen; Mice; Mice, Inbred C57BL; Neuroglia; Ovariectomy; Raloxifene Hydrochloride; Stereotaxic Techniques | 2003 |
Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biomarkers; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Memory; Neurons; Neuroprotective Agents; Neurotoxins; Oxidants; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators | 2004 |
The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences.
Topics: Aging; Alkaline Phosphatase; Animals; Bone Marrow Cells; Calcitriol; Cell Differentiation; Cells, Cultured; Creatine Kinase; Dexamethasone; Dihydrotestosterone; Estradiol; Female; Male; Orchiectomy; Osteoblasts; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred WKY; Sex Characteristics | 2005 |
Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats.
Topics: Acetylcholine; Aging; Animals; Aorta, Thoracic; Bone Density Conservation Agents; Calcium Chloride; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Nitric Oxide; Nitric Oxide Synthase Type III; Ovariectomy; Phenylephrine; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
Topics: Aging; Animals; Bone Density; Ethinyl Estradiol; Female; Lipids; Organ Size; Osteoporosis; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Tomography, X-Ray Computed; Uterus | 1995 |
The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Development; Bone Resorption; Cell Count; Cholesterol; Female; Organ Size; Osteoclasts; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tibia; Uterus | 1994 |
Oestrogenic effects of neonatal administration of raloxifene on hypothalamic-pituitary-gonadal axis in male and female rats.
Topics: Aging; Animals; Animals, Newborn; Anovulation; Epithelial Cells; Female; Follicle Stimulating Hormone; Gonads; Hyperprolactinemia; Hypothalamus; Infertility, Female; Luteinizing Hormone; Male; Pituitary Gland; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Vagina; Vaginal Smears; Weight Loss | 2001 |
Adenomyosis--a result of disordered stromal differentiation.
Topics: Administration, Oral; Aging; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; Cell Differentiation; Endometriosis; Estradiol; Female; Gene Expression Regulation; Growth Inhibitors; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Myometrium; Nerve Growth Factor; Oligonucleotide Array Sequence Analysis; Organ Size; Raloxifene Hydrochloride; Repressor Proteins; Selective Estrogen Receptor Modulators; Stromal Cells; Tamoxifen; Toremifene; Uterus | 2001 |
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Remodeling; Clomiphene; Diphosphonates; Female; Organ Size; Ovariectomy; Pamidronate; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia | 2002 |